Cardiovascular diseases are considered to be major comorbidity of diabetes, which estimates to affect about one-third (32.2%) of all people with diabetes and tend to increase dramatically over the decades. The main goal of the program is to highlight the evolving concepts of cardiometabolic medicine, newer therapeutic options for the management, to address the complex array and associated risk factors in the clinical scenario, overcome its burden and identify strategies to reinvent the delivery... Read more